Ledger.Open graph →
SEC Form D · filed February 24, 2022

Celeris Therapeutics, Inc

Offering
$4.7M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
GRAZ, C4
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Petr Sramek · Graz, C4DirectorMarius Swart · Graz, C4DirectorChristopher Trummer · Graz, C4Exec · DirectorKarel Kubias · Graz, C4DirectorJakob-Ferdinand Hohenberger · Graz, C4Exec · DirectorMarius Swart · Graz, C4DirectorChristopher Trummer · Graz, C4Exec · DirectorKarel Kubias · Graz, C4DirectorJakob-Ferdinand Hohenberger · Graz, C4Exec · DirectorPetr Sramek · Graz, C4Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗